Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi

By Luke C.J.   Huebner R.C.   Kasmiersky V.   Barbour A.G.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 739-746

Elsevier

Access to resources Recommend Favorite

OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant

By Erdile L.F.   Guy B.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 988-995

Elsevier

Access to resources Recommend Favorite

Immunization with a polyvalent OspA vaccine protects mice against Ioxides ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii

By Gern L.   Chang M.H.   Voet P.   Hauser P.   Lobet Y.  

Vaccine, Vol. 15, Iss. 14, 1997-10 ,pp. : 1551-1557

Elsevier

Access to resources Recommend Favorite

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi

By Golde W.T.   Burkot T.R.   Piesman J.   Dolan M.C.   Capiau C.   Hauser P.   Dequesne G.   Lobet Y.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 435-441

Elsevier

Access to resources Recommend Favorite

Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2

By Johnson B.J.B.   Sviat S.L.   Happ C.M.   Dunn J.J.   Frantz J.C.   Mayer L.W.   Piesman J.  

Vaccine, Vol. 13, Iss. 12, 1995-08 ,pp. : 1086-1094

Elsevier

Access to resources Recommend Favorite